ATOSSA THERAPEUTICS, INC. Long-term Debt and Lease Obligation
ATOSSA THERAPEUTICS, INC. (ATOS) had Long-term Debt and Lease Obligation of $0 as of 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2015-11-12
- 2015-09-30: Long-term Debt and Lease Obligation $0.00.
- 2015-06-30: Long-term Debt and Lease Obligation $12.53K.
- 2015-03-31: Long-term Debt and Lease Obligation $25.23K.
- 2014-12-31: Long-term Debt and Lease Obligation $49.22K.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-11-12 |
| 2015-06-30 | $12.53K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $25.23K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $49.22K 10-Q · filed 2015-11-12 |
| 2013-12-31 | $5.82K 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |